1st Quarter - Report

HANCE SCARBOROUGH for TITAN PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.

LobbyistCovered position, as disclosed
KENT R HANCE —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, REp. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2456 (115th)

Medical/Disease Research/Clinical Labs MED

Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.

LobbyistCovered position, as disclosed
KENT R HANCE —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2456 (115th)

Medicare/Medicaid MMM

Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.

LobbyistCovered position, as disclosed
KENT R HANCE —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2456 (115th)

Pharmacy PHA

Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.

LobbyistCovered position, as disclosed
KENT R HANCE —
MICHAEL TOMBERLIN Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2456 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.